“Older skin” is not a single diagnosis or treatment goal. It may refer to appearance, pigment spots, a history of sun exposure, fragility or a specific skin condition. An evidence-based answer begins by clarifying which concern is being addressed rather than assuming one peptide can answer all of them.
The SCENESSE label states that too few older participants were included to determine whether their responses differ from those of younger adults. That is a limitation of the available age-specific evidence, not proof of either unique danger or equal safety.
A long-term EPP cohort provides useful observations of medically supervised treatment, but it does not turn afamelanotide into a general intervention for skin ageing. The study's disease context and outcomes need to remain attached to its conclusions. Long follow-up alone does not make a population representative of every older adult.
Applicability involves more than age. The reason for treatment, other health conditions, concurrent medicines and the identity of a new pigment spot can all change the clinical question. A reader should not have to infer these boundaries from a broad “anti-ageing” headline.
It is especially important not to confuse making a spot less noticeable, darker or more contrastive with treating its underlying cause. Appearance is an observation, not a diagnosis. A changing lesion should be assessed on its own merits instead of being categorized automatically as a harmless age spot.
The absence of an age-specific trial also means that a confident cosmetic response timetable would be unsupported. Forum reports do not fill that gap, because the posters' diagnoses, exposures and follow-up differ and their product identity may be uncertain. Selected photographs are not a controlled comparison of ageing-related outcomes.
For an older adult, the useful next step is a clinician's assessment of the actual skin concern and available established care. This article provides no research-product regimen. It explains why disease-specific clinical evidence and limited older-adult representation should lead to a more focused discussion, not to a universal promise about restoring youthful skin.